1. Company introduction
Lane Immunotherapy Research Institute is a joint-stock company with a professional team focusing on the R&D immunotherapy treatments and international high-value health service development in China, including project investment, operation management, trusteeship merger, technology import and information consultation.
Because of the rapid development healthcare needs in China, PenYard devoted to the promotion of advanced medical technology and new style health service mode, setting up the platform for not only cooperation of mutual benefit between doctors, doctors and hospitals but also friendly communication between hospitals and enterprises.
In the new situation of deepening medical and health system, PenYard actively takes part in the state hospital reform and sincerely cooperate with all levels medical institutions for setting up one modernize professional chain medical group which is focus on high-value health medical industry including medical, recovery, retirement, research and teaching in the whole China.
In the future of 3 years, PenYard will invest and found 100 high-level chained clinics along China’s most affluent area. These clinics will provide excellent service to satisfy the healthcare needs of middle to upper-middle class Chinese.
2. Our structure
3. R&D center
We collaborate with top universities and scientific institutions both from China and America. Molecular biology, antigen & antibody, cell culture and other related bio-medical engineering platforms are set up in our lab. A GMP workshop is establishing to satisfy the needs of pre-clinical or clinical trials.
Our research and development team composed of top-ranking research personnel both domestically and internationally. Among them, half of the staff has master or doctor’s degree, while more than 90% of them hold bachelor or advanced degrees.
4. our manufacturing base and warehouse
5. Our missions
To contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life span.
To direct our growth in the areas of biomedical engineering where we display maximum strength and ability; to gather people and facilities that tend to augment these areas; to continuously build on these areas through education and knowledge assimilation; to avoid participation in areas where we cannot make unique and worthy contributions.
we are committed to a healthy world. We are setting ambitious goals for the future as we build upon multiple initiatives to preserve our environment, focus our philanthropic efforts on making affordable, quality healthcare available globally, and support socially responsible policies and programs
6. Talent team
President and Chief Executive Officer
Chief Technology Officer
Lisa Mao, PhD, MD. Dr. Mao graduated from Medical Center of Fudan University, Shanghai, P..R. China. In 2005, she went to USA for stroke research. As a PI, she got an American Heart Associate (AHA) fund in 2007. She also participated in couple of NIH funded projects as co-PI in 2006 to 2009. In 2010, she was appointed as the CTO of Asialand Bio-Med Technology Co., Ltd. In 2011, Her research project in Asialand Bio-Med Company is awarded National Key Science & Technology Funds for the State Program of Innovative Drug Development
Chief Financial Officer
Brian Li. PhD.
Dr. Li, graduated from Shanghai Finance & Economics University, having 10 years of finance and project investment experience.
Chief Sales & Marketing Officer
Tomas Feng, MS
Mr Feng, 7 years of medical devices and 5 years of medicine sales & marketing experience with wide sales channels and network.
Intellectural Property and Products Registration Officer
Nancy Zhao, MS
Mrs Zhao, successfully registed 7 invitro diagnostic kits and 3 medical devices. 8 of the products has been approved by State Food and Drug Administration of China
Chief Administration Officier
Mei, Wang, MS
Mrs Wang, 8 years of expericence working at big Chinese private companies responsible for company administration
We have a highly efficient and qualified management team with experts from all walks of life. Besides that, we have a group of young employees The average age is 30 . All the staff have good education backgrounds. Our company is also equipped with experimental project teams made up of senior experts to safeguard the clinical research process professional and efficient.
7. Company culture
We regard staff as our greatest asset. Every product, every invention, every breakthrough that we have introduced was powered by our people.
We believe that success only matters when employees are valued, respected and treated fairly. Therefore, we foster and reward values-based leadership.
8. Core business
1. innovative products
Innovative drug for stroke (is researching & developing)
2. products we distribute
In vitro diagnostic reagents
Decontamination (hospital equipped with liquid)
9. Achievements and honors
|September 2011, awarded “Innovative and Enterpreneur Talents of Jiangsu Province”||October 2011, listed as “the Key Technology R&D Program of Wujin District, Changzhou City”|
|October 2011, awarded National Key Science & Technology Funds for the State Program of Innovative Drug Development||July 2011, listed as “the Key Technology R&D Program of Jiangsu Province”|
|July 2009, awarded "the Key Recommended Project of the 5th Changzhou Entrepreneur Talents of Overseas Returnee"|